(Q77845020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C viral infection in the United States (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

1 reference

1 reference

1 reference

United States of America

1 reference

Miguel R Arguedas

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Gustavo R Heudebert

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Michael B Fallon

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Aaron A Stinnett

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

The American Journal of Gastroenterology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

721-728

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11922569%20AND%20SRC:MED&resulttype=core&format=json

Fulminant Hepatitis Associated with Hepatitis A Virus Superinfection in Patients with Chronic Hepatitis C

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X

Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X

Pretreatment evaluation of chronic hepatitis C: risks, benefits, and costs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X

The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X

Cost-effectiveness of combination therapy for naive patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2002.05554.X